{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:49:13Z","timestamp":1782395353934,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cmi.2020.03.001","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T12:48:44Z","timestamp":1583758124000},"page":"1355-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function"],"prefix":"10.1016","volume":"26","author":[{"given":"T.","family":"ten Doesschate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Wijma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.03.001_bib1","first-page":"270","article-title":"NHG-Standaard Urineweginfecties (derde herziening)","volume":"56","author":"Van Pinxteren","year":"2013","journal-title":"Huisarts Wet"},{"key":"10.1016\/j.cmi.2020.03.001_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2020.03.001_bib3","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","article-title":"Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials","volume":"65","author":"Falagas","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.001_bib4","doi-asserted-by":"crossref","DOI":"10.3821\/1913-701X-142.5.248","article-title":"A\u00a0retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment","volume":"142","author":"Bains","year":"2009","journal-title":"Can Pharm J"},{"key":"10.1016\/j.cmi.2020.03.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics6040024","article-title":"Fosfomycin: pharmacological, clinical and future perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics"},{"key":"10.1016\/j.cmi.2020.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.2165\/00003495-198223060-00001","article-title":"Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2020.03.001_bib7","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/jac\/dky255","article-title":"Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline","volume":"73","author":"Wijma","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.001_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1756287215581556","article-title":"Effectiveness and safety of nitrofurantoin in outpatient male veterans","volume":"7","author":"Ingalsbe","year":"2015","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.cmi.2020.03.001_bib9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00228-013-1520-x","article-title":"Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care","volume":"69","author":"Geerts","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cmi.2020.03.001_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12913-018-3528-5","article-title":"Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners\u2019 Network (JGPN)","volume":"18","author":"Smeets","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cmi.2020.03.001_bib11","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function - measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.03.001_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1373\/clinchem.2005.0525144","article-title":"Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program","volume":"52","author":"Myers","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cmi.2020.03.001_bib13","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Inter"},{"key":"10.1016\/j.cmi.2020.03.001_bib14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.03.001_bib15","series-title":"Summary of product characteristics","year":"2015"},{"key":"10.1016\/j.cmi.2020.03.001_bib16","series-title":"Macrobid\u00ae (nitrofurantoin monohydrate\/macrocrystals) Capsules product information","first-page":"1","author":"Procter & Gamble Pharmaceuticals","year":"2003"},{"key":"10.1016\/j.cmi.2020.03.001_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1R352","article-title":"Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL\/min: Looking for the evidence","volume":"47","author":"Oplinger","year":"2013","journal-title":"Ann. Pharmacother"},{"key":"10.1016\/j.cmi.2020.03.001_bib18","series-title":"Trimethoprim 100-300 mg tablets. Summary of product characteristics","year":"2017"},{"key":"10.1016\/j.cmi.2020.03.001_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/dkn147","article-title":"Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue","volume":"62","author":"Wisell","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.001_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmi.2017.08.023","article-title":"High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers","volume":"24","author":"Wijma","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.03.001_bib21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jac\/dkz095","article-title":"The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study","volume":"74","author":"Huttner","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.001_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJM196805092781902","article-title":"Effect of renal function on urinary recovery of orally administered nitrofurantoin","volume":"278","author":"Sachs","year":"1968","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.03.001_bib23","first-page":"343","article-title":"Nitrofurantoin, sulfamethizole and cephalexin urinary concentration in unequally functioning pyelonephritic kidneys","volume":"114","author":"Sullivan","year":"1975","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cmi.2020.03.001_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/33.suppl_A.121","article-title":"Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice","volume":"33","author":"Spencer","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.001_bib25","first-page":"181","article-title":"The treatment of urinary tract infections in out-patients. a double-blind comparison between trimethoprim and nitrofurantoin","volume":"9","author":"Sander","year":"1981","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.cmi.2020.03.001_bib26","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.cmi.2020.03.001_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01871127","article-title":"Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women","volume":"15","author":"Van Pienbroek","year":"1993","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.cmi.2020.03.001_bib28","series-title":"Nethmap\/Maran 2018, Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands","author":"Greeff","year":"2018"},{"key":"10.1016\/j.cmi.2020.03.001_bib29","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.3399\/bjgp17X693641","article-title":"Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study","volume":"67","author":"Butler","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2020.03.001_bib30","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women a randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.cmi.2020.03.001_bib31","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.3399\/bjgp17X689641","article-title":"Antibiotic prescribing during office hours and out-of-hours: a comparison of quality and quantity in primary care in The Netherlands","volume":"67","author":"Debets","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2020.03.001_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1087\/20150211","article-title":"Beyond authorship: attribution, contribution, collaboration, and credit","volume":"28","author":"Brand","year":"2015","journal-title":"Learn Publ"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20301439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20301439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:06Z","timestamp":1761117906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20301439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1198743X20301439"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.03.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}